SRPT, HTZ, ASAN and more
Check out the companies making headlines in midday trading. Sarepta Therapeutics — Shares of the biopharma company surged 33% after the U.S. Food and Drug Administration approved the expanded use of the company’s gene therapy, Elevidys, for Duchenne muscular dystrophy. The FDA granted traditional approval of the therapy for patients 4 years and older who […]